GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 30.15
+0.10 (0.33%)
Sep 8, 2026, 11:19 AM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.25 billion as of September 4, 2026. Its market cap has decreased by -49.15% in one year.
Market Cap
1.25B
Enterprise Value
1.28B
Revenue
664.94M
Ranking
n/a
PE Ratio
73.23
Stock Price
30.15
ChartMarket Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.25B, a decrease of -42.69%. That is a compound annual growth rate of -5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.25B | -37.72% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.25B |
| Merdury Biopharmaceutical | 2.16B |
| TSH Biopharm Corporation | 1.93B |
| Excelsior Biopharma | 1.15B |
| Prince Pharmaceutical | 1.06B |
| DV Biomed | 999.53M |
| Anxo Pharmaceutical | 969.47M |
| Original BioMedicals | 881.87M |